2022 Scientific Sessions

Featured Clinical Research: Part 2

Contemporary In-Hospital Outcomes and Temporal Trends of Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO International Registry
Spyridon Kostantinis, MD1, Bahadir Simsek, MD1, Judit Karacsonyi, MD, PhD1, Khaldoon Alaswad, M.D., FSCAI2, Oleg Krestyaninov, M.D.3, Dmitrii Khelimskii, M.D.4, Dimitrios Karmpaliotis, M.D., FSCAI5, Farouc A. Jaffer, M.D., Ph.D., FSCAI6, Jaikirshan Khatri, M.D., FSCAI7, Paul Poommipanit, M.D., FSCAI8, James W. Choi, M.D., FSCAI9, Wissam A Jaber, M.D., FSCAI10, Stéphane Rinfret, M.D., FSCAI11, William J. Nicholson, M.D.12, Mitul P. Patel, M.D., FSCAI13, Ehtisham Mahmud, M.D., MSCAI14, Philip Dattilo, M.D.15, Şevket Görgülü, MD16, Michail Koutouzis, M.D., Ph.D.17, Ioannis Tsiafoutis, M.D.17, Basem Elbarouni, M.B.B.S.18, Abdul M. Sheikh, MD19, Barry F. Uretsky, M.D., MSCAI20, Ahmed Elguindy, MD21, Brian Keith Jefferson, MD, FSCAI22, Taral Patel, M.D.23, Jason R. Wollmuth, MD, FSCAI24, Robert F. Riley, M.D., FSCAI25, Stewart M. Benton Jr., M.D.26, Rhian E. Davies, DO MS, FSCAI27, Raj H. Chandwaney, M.D., FSCAI28, Catalin Toma, M.D.29, Robert W. Yeh, M.D., FSCAI30, Daniel Schimmel, MD, FSCAI31, Nidal Abi Rafeh, MD32, Ömer Göktekin, MD33, Dr. Jimmy L Kerrigan, M.D., FACC, FSCAI34, M. Nicholas Burke, M.D.1, Olga C Mastrodemos, BA35, Bavana V Rangan, BDS, MPH35 and Emmanouil S. Brilakis, MD, PhD, FSCAI1, (1)Minneapolis Heart Institute® - Abbott Northwestern Hospital, Minneapolis, MN, (2)Henry Ford Hospital, Detroit, MI, (3)Federal State Institution Academician E.N.Meshalkin, Novosibirsk, Novosibirskaya oblast, Russian Federation, (4)Meshalkin Novosibrisk Research Institute, Novosibirsk, Russian Federation, (5)Atlantic Health Morristown Medical Center, Morristown , NJ, (6)Massachusetts General Hospital, Boston, MA, (7)Cleveland Clinic Main Campus, Cleveland, OH, (8)University Hospitals Cleveland Medical Center, Beachwood, OH, (9)Texas Health Heart and Vascular Specialists: Presbyterian Hospital, Dallas, TX, (10)Emory University Hospital, Atlanta, GA, (11)Georgia Heart Institute, Atlanta, GA, (12)Emory HealthCare, York, PA, (13)Intermountain Healthcare, Salt Lake City, UT, (14)The University of California, San Diego, La Jolla, CA, (15)University of Colorado Health Harmony, Fort Collins, CO, (16)Department Cardiology, Acibadem Kocaeli Hospital, Kocaeli, Turkey, Kadıköy/İstanbul, Turkey, (17)Hellenic Red Cross Hospital of Athens, Athens, Greece, (18)St. Boniface General Hospital, Winnipeg, MB, Canada, (19)Wellstar Health System, Marietta, GA, (20)University of Arkansas for Medical Sciences, Fort Smith, AR, (21)Magdi Yacoub Hospital, Cairo, Egypt, (22)TriStar Centennial Medical Center, Nashville, TN, (23)Centennial Heart, LLC, Nashville, TN, (24)Providence Heart & Vascular, Portland, OR, (25)Overlake Medical Center, Sammamish, WA, (26)WellSpan Health, York, PA, (27)WellSpan Cardiology - York, York, PA, (28)Oklahoma Heart Institute, Tulsa, OK, (29)University of Pittsburgh Medical Center, Pittsburgh, PA, (30)Beth Israel Deaconess Medical Center, Boston, MA, (31)Northwestern Memorial Hospital, Chicago, IL, (32)North Oaks Health System, Hammond, LA, (33)Memorial Bahcelievler Hospital, Istanbul, Turkey, (34)Ascension Saint Thomas Heart, Nashville, TN, (35)Minneapolis Heart Institute Foundation, Minneapolis, MN
Update From the Safety Assessment of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices (SAFE-PAD) Study
Eric Secemsky, MD, MSc, FSCAI1, Yang Song, MSc2, Marc L Schermerhorn, MD2 and Robert W. Yeh, M.D., FSCAI2, (1)Beth Israel Deaconess Medical Center, Newton, MA, (2)Beth Israel Deaconess Medical Center, Boston, MA
No-Implant Interatrial Shunt for Heart Failure: Multicenter Clinical Outcomes
Colin M. Barker, MD, FSCAI1, Gerard Wilkins2, Benjamin Wilkins2, Robert Gooley3, Siobahn Lockwood3, Peter S. Fail, M.D., FSCAI4, Christopher Meduri, M.D.5, Kari Feldt, M.D.5, Darrell Solet4, Jacob Kriegel6 and Tamaz Shaburishvili7, (1)Vanderbilt University Medical Center, Nashville, TN, (2)Dunedin Public Hospital, Dunedin, New Zealand, (3)MonashHeart, Clayton, VIC, Australia, (4)Cardiovascular Institute of the South, Houma, LA, (5)Karolinska University Hospital, Stockholm, Sweden, (6)Alleviant Medical, New York, NY, (7)Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia
Clopidogrel Monotherapy vs. Aspirin Monotherapy for Chronic Maintenance Beyond 12 Months After PCI Among Patients With a High Risk of Ischemic or Bleeding Events
Dr. Haoyu Wang1, Bo Xu2 and Kefei Dou2, (1)Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, (2)Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
See more of: Featured Sessions